Advanced Accelerator Applications SA
General
Total Cases9
Active Cases4
Patents21
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
L3
A
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 12/20/24 | Summons Issued as to Curium International Trading BV on 12/20/2024; Curium Netherlands BV on 12/20/2024; Curium US Holdings LLC on 12/20/2024; Curium US LLC on 12/20/2024. (Attachments: # [1] Summons Issued Cirium Us Holdings LLC, # [2] Summons Issued Cirium US LLC, # [3] Summons Issued Cirium International Trading BV)(scs) (Entered: 12/20/2024) | |
| 12/20/24 | Summons Issued as to Curium International Trading BV on 12/20/2024; Curium Netherlands BV on 12/20/2024; Curium US Holdings LLC on 12/20/2024; Curium US LLC on 12/20/2024. (Attachments: # [1] Summons Issued Cirium Us Holdings LLC, # [2] Summons Issued Cirium US LLC, # [3] Summons Issued Cirium International Trading BV)(scs) (Entered: 12/20/2024) | |
| 12/20/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc. filed by Advanced Accelerator Applications USA, Inc., Advanced Accelerator Applications SA. (scs) (Entered: 12/20/2024) | |
| 12/20/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc. filed by Advanced Accelerator Applications USA, Inc., Advanced Accelerator Applications SA. (scs) (Entered: 12/20/2024) | |
| 12/20/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,168,063. (scs) (Entered: 12/20/2024) | |
| 12/20/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,168,063. (scs) (Entered: 12/20/2024) | |
| 12/20/24 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: July 25, 2038. (scs) (Entered: 12/20/2024) | |
| 12/20/24 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: July 25, 2038. (scs) (Entered: 12/20/2024) | |
| 12/20/24 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 12/20/2024) | |
| 12/20/24 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 12/20/2024) |